Viewing Study NCT03097159


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2026-02-25 @ 6:32 PM
Study NCT ID: NCT03097159
Status: WITHDRAWN
Last Update Posted: 2018-07-03
First Post: 2017-03-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Costoclavicular Brachial Plexus Block and Supraclavicular Brachial Plexus Block
Sponsor: Ajou University School of Medicine
Organization:

Study Overview

Official Title: Comparison of Costoclavicular Brachial Plexus Block and Supraclavicular Brachial Plexus Block
Status: WITHDRAWN
Status Verified Date: 2018-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Surgeon refuse the proposal, so we can's enroll the patients
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: BPB
Brief Summary: The investigator will compare Costoclavicular approach of infraclavicular block and supraclavicular block. Especially, the incidence of phrenic nerve palsy and the quality of block.
Detailed Description: Costoclavicular brachial plexus block is a recently developed approach of infraclavicular brachial plexus block. Using ultrasound, all of 3 cords are well visible in single plane. Compared to conventional infraclavicular block, it needs smaller amount of local anesthetics.

Supraclavicular brachial plexus block is known as spinal anesthesia of upper extremities. It provides fast and good quality of anesthesia and analgesia. But some studies showed that there are over 50% of phrenic nerve palsy in supraclavicular block.

In this study, the investigator will compare phrenic nerve palsy incidence and block quality between Costoclavicular block and supraclavicular block using ultrasound.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: